» Articles » PMID: 22076410

Pseudomonas Aeruginosa Inhibits the Growth of Cryptococcus Species

Overview
Journal Mycopathologia
Date 2011 Nov 15
PMID 22076410
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa is a ubiquitous and opportunistic bacterium that inhibits the growth of different microorganisms, including Gram-positive bacteria and fungi such as Candida spp. and Aspergillus fumigatus. In this study, we investigated the interaction between P. aeruginosa and Cryptococcus spp. We found that P. aeruginosa PA14 and, to a lesser extent, PAO1 significantly inhibited the growth of Cryptococcus spp. The inhibition of growth was observed on solid medium by the visualization of a zone of inhibition of yeast growth and in liquid culture by viable cell counting. Interestingly, such inhibition was only observed when P. aeruginosa and Cryptococcus were co-cultured. Minimal inhibition was observed when cell-cell contact was prevented using a separation membrane, suggesting that cell contact is required for inhibition. Using mutant strains of Pseudomonas quinoline signaling, we showed that P. aeruginosa inhibited the growth of Cryptococcus spp. by producing antifungal molecules pyocyanin, a redox-active phenazine, and 2-heptyl-3,4-dihydroxyquinoline (PQS), an extracellular quorum-sensing signal. Because both P. aeruginosa and Cryptococcus neoformans are commonly found in lung infections of immunocompromised patients, this study may have important implication for the interaction of these microbes in both an ecological and a clinical point of view.

Citing Articles

Alkyl quinolones mediate heterogeneous colony biofilm architecture that improves community-level survival.

Weaver A, Jia J, Cutri A, Madukoma C, Vaerewyck C, Bohn P J Bacteriol. 2024; 206(4):e0009524.

PMID: 38564677 PMC: 11025328. DOI: 10.1128/jb.00095-24.


Intestinal bacteria-a powerful weapon for fungal infections treatment.

Cong L, Chen C, Mao S, Han Z, Zhu Z, Li Y Front Cell Infect Microbiol. 2023; 13:1187831.

PMID: 37333850 PMC: 10272564. DOI: 10.3389/fcimb.2023.1187831.


Species Induce the Production of Siderophores by in a Cystic Fibrosis Mimic Environment.

Mello T, Barcellos I, Lackner M, Branquinha M, Santos A J Fungi (Basel). 2023; 9(5).

PMID: 37233213 PMC: 10219197. DOI: 10.3390/jof9050502.


The two faces of pyocyanin - why and how to steer its production?.

Jablonska J, Augustyniak A, Dubrowska K, Rakoczy R World J Microbiol Biotechnol. 2023; 39(4):103.

PMID: 36864230 PMC: 9981528. DOI: 10.1007/s11274-023-03548-w.


Bacterial-fungal metabolic interactions within the microbiota and their potential relevance in human health and disease: a short review.

Lapiere A, Richard M Gut Microbes. 2022; 14(1):2105610.

PMID: 35903007 PMC: 9341359. DOI: 10.1080/19490976.2022.2105610.


References
1.
Machan Z, Taylor G, Pitt T, COLE P, Wilson R . 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother. 1992; 30(5):615-23. DOI: 10.1093/jac/30.5.615. View

2.
Feldmesser M, Tucker S, Casadevall A . Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 2001; 9(6):273-8. DOI: 10.1016/s0966-842x(01)02035-2. View

3.
Tan M, Ausubel F . Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci U S A. 1999; 96(2):715-20. PMC: 15202. DOI: 10.1073/pnas.96.2.715. View

4.
Hogan D, Kolter R . Pseudomonas-Candida interactions: an ecological role for virulence factors. Science. 2002; 296(5576):2229-32. DOI: 10.1126/science.1070784. View

5.
Kerr J . Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infect. 1994; 28(3):305-10. DOI: 10.1016/s0163-4453(94)91943-7. View